Latest news with #MukulAgrawal
Time of India
4 days ago
- Business
- Time of India
Ahead of IPO, ArisInfra Solutions garners ₹225 crore from anchor investors
NEW DELHI: ArisInfra Solutions Ltd on Tuesday said it has raised Rs 225 crore from anchor investors, a day ahead of the launch of its initial share sale for public subscription. Astorne Capital VCC , Niveshaay Hedgehogs Fund , Citigroup Global Markets Mauritius , Rajasthan Global Securities , Sunrise Investment, Nexus Global Opportunities Fund, Zeal Global Opportunities Fund, Saint Capital Fund, Beacon Stone Capital among others have been allotted shares in the anchor round. According to a circular uploaded on BSE's website, ArisInfra Solutions allocated 1,01,26,946 shares to 15 funds at Rs 222 per equity share, which is the upper end of the IPO price band. The nearly Rs 500-crore IPO will open for subscription on June 18 and conclude on June 20. The price band has been set at Rs 210 to Rs 222 per share for the public issue. The IPO is completely a fresh issue of equity shares worth Rs 499.6 crore with no offer for sale (OFS) component. At the upper end of the price band, the company is valued at nearly Rs 1,800 crore. Proceeds of the issue will be used for funding the working capital requirements of the company, investment in the subsidiary, Buildmex-Infra, for funding its working capital, purchase of partial shareholding from existing shareholders of its subsidiary, ArisUnitern Re Solutions Pvt Ltd, repayment of loan and for general corporate purposes. Earlier, the company attracted pre-IPO placement from Param Capital founder Mukul Agrawal, along with asset management firm Singularity Ventures, and Sundar Iyer, founder of Suryoday Trust and Rays of Life Foundation. Arisinfra Solutions is a B2B technology-enabled company, focusing on simplifying and digitizing the procurement process for construction materials. Between April 1, 2021, and March 31, 2024, the company has delivered 10.35 million metric tonnes of construction materials, including aggregates, ready-mix concrete, steel, cement, construction chemicals and walling solutions, utilizing 1,458 vendors and serving 2,133 customers across 963 pin codes in various cities. JM Financial, IIFL Securities and Nuvama are the book running lead managers to the public issue. The equity shares are expected to be listed on June 25 on the stock exchanges.
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
Ahead of IPO, ArisInfra Solutions garners ₹225 crore from anchor investors
ArisInfra Solutions Ltd on Tuesday said it has raised Rs 225 crore from anchor investors, a day ahead of the launch of its initial share sale for public subscription. Astorne Capital VCC, Niveshaay Hedgehogs Fund, Citigroup Global Markets Mauritius, Rajasthan Global Securities, Sunrise Investment, Nexus Global Opportunities Fund, Zeal Global Opportunities Fund, Saint Capital Fund, Beacon Stone Capital among others have been allotted shares in the anchor round. According to a circular uploaded on BSE's website, ArisInfra Solutions allocated 1,01,26,946 shares to 15 funds at Rs 222 per equity share, which is the upper end of the IPO price band. The nearly Rs 500-crore IPO will open for subscription on June 18 and conclude on June 20. The price band has been set at Rs 210 to Rs 222 per share for the public issue. The IPO is completely a fresh issue of equity shares worth Rs 499.6 crore with no offer for sale (OFS) component. At the upper end of the price band, the company is valued at nearly Rs 1,800 crore. Proceeds of the issue will be used for funding the working capital requirements of the company, investment in the subsidiary, Buildmex-Infra, for funding its working capital, purchase of partial shareholding from existing shareholders of its subsidiary, ArisUnitern Re Solutions Pvt Ltd, repayment of loan and for general corporate purposes. Earlier, the company attracted pre-IPO placement from Param Capital founder Mukul Agrawal, along with asset management firm Singularity Ventures, and Sundar Iyer, founder of Suryoday Trust and Rays of Life Foundation. Arisinfra Solutions is a B2B technology-enabled company, focusing on simplifying and digitizing the procurement process for construction materials. Between April 1, 2021, and March 31, 2024, the company has delivered 10.35 million metric tonnes of construction materials, including aggregates, ready-mix concrete, steel, cement, construction chemicals and walling solutions, utilizing 1,458 vendors and serving 2,133 customers across 963 pin codes in various cities. JM Financial, IIFL Securities and Nuvama are the book running lead managers to the public issue. The equity shares are expected to be listed on June 25 on the stock exchanges.
Time of India
5 days ago
- Business
- Time of India
Ahead of IPO, ArisInfra Solutions garners Rs 225 crore from anchor investors
New Delhi, ArisInfra Solutions Ltd on Tuesday said it has raised Rs 225 crore from anchor investors , a day ahead of the launch of its initial share sale for public subscription. Astorne Capital VCC, Niveshaay Hedgehogs Fund, Citigroup Global Markets Mauritius, Rajasthan Global Securities, Sunrise Investment, Nexus Global Opportunities Fund, Zeal Global Opportunities Fund, Saint Capital Fund, Beacon Stone Capital among others have been allotted shares in the anchor round. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Move That Changed Their Lives – See How It Works Esseps | Investing | Learn More Learn More Undo According to a circular uploaded on BSE's website, ArisInfra Solutions allocated 1,01,26,946 shares to 15 funds at Rs 222 per equity share, which is the upper end of the IPO price band. The nearly Rs 500-crore IPO will open for subscription on June 18 and conclude on June 20. The price band has been set at Rs 210 to Rs 222 per share for the public issue. The IPO is completely a fresh issue of equity shares worth Rs 499.6 crore with no offer for sale (OFS) component. Live Events At the upper end of the price band, the company is valued at nearly Rs 1,800 crore. Proceeds of the issue will be used for funding the working capital requirements of the company, investment in the subsidiary, Buildmex-Infra, for funding its working capital, purchase of partial shareholding from existing shareholders of its subsidiary, ArisUnitern Re Solutions Pvt Ltd, repayment of loan and for general corporate purposes. Earlier, the company attracted pre-IPO placement from Param Capital founder Mukul Agrawal, along with asset management firm Singularity Ventures, and Sundar Iyer, founder of Suryoday Trust and Rays of Life Foundation. Arisinfra Solutions is a B2B technology-enabled company, focusing on simplifying and digitizing the procurement process for construction materials . Between April 1, 2021, and March 31, 2024, the company has delivered 10.35 million metric tonnes of construction materials, including aggregates, ready-mix concrete, steel, cement, construction chemicals and walling solutions, utilizing 1,458 vendors and serving 2,133 customers across 963 pin codes in various cities. JM Financial , IIFL Securities and Nuvama are the book running lead managers to the public issue. The equity shares are expected to be listed on June 25 on the stock exchanges. PTI
Economic Times
5 days ago
- Business
- Economic Times
Ahead of IPO, ArisInfra Solutions garners Rs 225 crore from anchor investors
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel New Delhi, ArisInfra Solutions Ltd on Tuesday said it has raised Rs 225 crore from anchor investors , a day ahead of the launch of its initial share sale for public Capital VCC, Niveshaay Hedgehogs Fund, Citigroup Global Markets Mauritius, Rajasthan Global Securities, Sunrise Investment, Nexus Global Opportunities Fund, Zeal Global Opportunities Fund, Saint Capital Fund, Beacon Stone Capital among others have been allotted shares in the anchor to a circular uploaded on BSE's website, ArisInfra Solutions allocated 1,01,26,946 shares to 15 funds at Rs 222 per equity share, which is the upper end of the IPO price nearly Rs 500-crore IPO will open for subscription on June 18 and conclude on June 20. The price band has been set at Rs 210 to Rs 222 per share for the public IPO is completely a fresh issue of equity shares worth Rs 499.6 crore with no offer for sale (OFS) the upper end of the price band, the company is valued at nearly Rs 1,800 of the issue will be used for funding the working capital requirements of the company, investment in the subsidiary, Buildmex-Infra, for funding its working capital, purchase of partial shareholding from existing shareholders of its subsidiary, ArisUnitern Re Solutions Pvt Ltd, repayment of loan and for general corporate the company attracted pre-IPO placement from Param Capital founder Mukul Agrawal, along with asset management firm Singularity Ventures, and Sundar Iyer, founder of Suryoday Trust and Rays of Life Solutions is a B2B technology-enabled company, focusing on simplifying and digitizing the procurement process for construction materials Between April 1, 2021, and March 31, 2024, the company has delivered 10.35 million metric tonnes of construction materials, including aggregates, ready-mix concrete, steel, cement, construction chemicals and walling solutions, utilizing 1,458 vendors and serving 2,133 customers across 963 pin codes in various cities. IIFL Securities and Nuvama are the book running lead managers to the public issue. The equity shares are expected to be listed on June 25 on the stock exchanges. PTI
&w=3840&q=100)
Business Standard
10-06-2025
- Business
- Business Standard
Mukul Agrawal portfolio stock hits record high; zooms 75% from March low
Share price of OneSource Specialty Pharma today: Shares of OneSource Specialty Pharma hit a new high of ₹2,031.45, as they rallied 5 per cent on the BSE in Tuesday's intra-day trade in otherwise a subdued market. At 01:49 PM, the BSE Sensex was up 0.02 per cent at 82,455. In the past month, the stock price of the pharmaceutical company has surged 28 per cent. It has bounced back 75 per cent from its March low price of ₹1,163.05 on the BSE. OneSource's Bangalore unit received VAI classification from USFDA OneSource Specialty Pharma today announced that its flagship facility in Bangalore received a "Voluntary Action Indicated" (VAI) classification from the US Food and Drug Administration (USFDA), confirming its continued compliance. Following an inspection of the company's flagship facility from March 20 to March 28, 2025, the USFDA issued a Form 483 with four observations. Based on the company's comprehensive response and commitments, the agency has classified the inspection outcome as VAI, officially closing the inspection, the company said in its exchange filing. Track LIVE Stock Market Updates Today Mukul Mahavir Agrawal holds over 1% stake in OneSource Ace Investor Mukul Mahavir Agrawal held 1.5 million equity shares representing a 1.31 per cent stake in OneSource Specialty Pharma at the end of the March 2025 quarter, the shareholding pattern data shows. As per the latest corporate shareholdings filed, Mukul Agrawal publicly holds stakes in Indo Count Industries, Deepak Fertilisers & Petrochemicals Corporation, Neuland Laboratories, Radico Khaitan, Nuvama Wealth Management, BSE and PTC Industries. India Ratings and Research (Ind-Ra) rating rationale The Positive Outlook reflects Ind-Ra's expectation that OneSource Specialty Pharma would continue to report healthy revenue/Ebitda in its softgel capsules (SGC)/injectable business (financials available only from Q3FY25 onwards) and the improved visibility on the commercialisation of its Glucagon-like peptide 1 (GLP-1) contracts. The drug device combination (DDC) segment is likely to register moderate growth in FY26, supported by a strong pipeline of master service agreement (MSA) contracts and the initiation of commercial supply agreement (CSA) revenues. Despite OneSource Specialty Pharma's capex plans for capacity enhancement, Ind-Ra expects the credit metrics to remain healthy in the near-to-medium term, aided by long-term contracts for the supply of GLP-1 products to its global clients. Ind-Ra said it will monitor OneSource Specialty Pharma's evolving revenue profile, product concentration risk and price volatility, which could have a bearing on its business profile in the medium-to-long term. Ind-Ra will also monitor the outcome of the arbitration in lieu of contingent liabilities of ₹1,000 crore on the books and its impact on the credit metrics, if any. About OneSource Specialty Pharma OneSource Specialty Pharma is a pure-play speciality pharmaceutical Contract Development and Manufacturing Organization (CDMO). The company focuses on the development and manufacturing of complex pharmaceutical products, including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatin capsules). Until FYE24, OneSource Specialty Pharma had capabilities in biologics and drug-device combination (DDC) products. In FY25, Strides Pharma Science's softgels business and Steriscience Pharma Pvt Ltd's injectables business was merged with OneSource Specialty Pharma, thereby augmenting OneSource Specialty Pharma's scale of operations.
